Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Peripheral mechanisms of nociceptor modulation by NPY
Genetics of Chd Factors in Japanese Americans
Large Bowel Adenomatous Polyp Dietary Intervention
Expression of C4 Genes in Development of Maize Leaf Cell
The Synthesis of Some Complex Cytotoxic Compounds
Recently added grants:
Chiral Complexes Designed to Catalyzed Organic Reactions
Exploring the relationship of water flow across the RPE and mutant-MYO7A/Usher 1B
Intracellular Functions of the Bioactive Sphingolipid Metabolites Sphingosine and Sphingosine-1-phosphate
Nickel-Catalyzed Coupling Reactions of Alkyl Electrophiles
Primordially conserved principles governing mucosal immune responses to microbiota
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67185-2-0-1
Application #
7574879
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Colorado Denver
$385,356
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Badesch, David /
$360,397
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant